Indegene, a digital-first partner to global life sciences companies, is strengthening its consulting services to better support clients through complex business transformations. As the healthcare and pharmaceutical sectors face rapid technological shifts and increasing pressure to innovate, companies are turning to partners who can deliver both strategic guidance and practical execution. Indegene’s refreshed consulting model is designed to bridge this gap—offering not only strategic direction but also hands-on support to implement large-scale change across the entire business landscape.
This move reflects Indegene’s commitment to helping life sciences organizations tackle urgent challenges with agility, measurable impact, and strong accountability. It’s a significant milestone in the company’s ongoing efforts to align closely with the shifting needs of the industry.
“Our clients are asking for more than just high-level advice—they want a partner who can guide strategy and roll up their sleeves to deliver outcomes,” said Manish Gupta, Chairman and CEO. “We’re scaling our consulting capabilities to meet that expectation and reinforce our role as a trusted transformation partner in the life sciences space.”
To lead this initiative, Gobin Chandra has been appointed Head of the Integrated Consulting Practice. Currently overseeing the company’s European operations, Gobin brings transformation expertise from his time at Bain & Company and will be responsible for shaping the group’s combined strategy and execution offerings.
Over the last ten years, Indegene has steadily built its consulting strength—bolstered by its 2020 acquisition of DT Consulting, known for its focus on digital transformation and customer experience. The company has now deepened that expertise with the addition of WARN & Co, a UK-based firm specializing in organizational redesign and business model transformation. This latest acquisition boosts Indegene’s ability to deliver comprehensive, large-scale change for global life sciences organizations.
